The conflict between treatment optimization and registration of radiopharmaceuticals with fixed activity posology in oncological nuclear medicine therapy

C Chiesa; KS Gleisner; G Flux; J Gear; S Walrand; K Bacher; U Eberlein; EP Visser; N Chouin; M Ljungberg; M Bardies; M Lassmann; L Strigari; Mark Konijnenberg

doi:10.1007/s00259-017-3707-3

The conflict between treatment optimization and registration of radiopharmaceuticals with fixed activity posology in oncological nuclear medicine therapy

C Chiesa, KS Gleisner, G Flux, J Gear, S Walrand, K Bacher, U Eberlein, EP Visser, N Chouin, M Ljungberg, M Bardies, M Lassmann, L Strigari, Mark Konijnenberg

Radiology & Nuclear Medicine

Research output: Contribution to journal › Article › Academic › peer-review

46 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	1783-1786
Number of pages	4
Journal	European Journal of Nuclear Medicine and Molecular Imaging
Volume	44
Issue number	11
DOIs	https://doi.org/10.1007/s00259-017-3707-3
Publication status	Published - 2017

Research programs

EMC MM-01-40-01

Access to Document

10.1007/s00259-017-3707-3

http://hdl.handle.net/1765/100235

Cite this

Chiesa, C., Gleisner, KS., Flux, G., Gear, J., Walrand, S., Bacher, K., Eberlein, U., Visser, EP., Chouin, N., Ljungberg, M., Bardies, M., Lassmann, M., Strigari, L., & Konijnenberg, M. (2017). The conflict between treatment optimization and registration of radiopharmaceuticals with fixed activity posology in oncological nuclear medicine therapy. European Journal of Nuclear Medicine and Molecular Imaging, 44(11), 1783-1786. https://doi.org/10.1007/s00259-017-3707-3

@article{f5a8141de409407780b2243050a073b0,

title = "The conflict between treatment optimization and registration of radiopharmaceuticals with fixed activity posology in oncological nuclear medicine therapy",

author = "C Chiesa and KS Gleisner and G Flux and J Gear and S Walrand and K Bacher and U Eberlein and EP Visser and N Chouin and M Ljungberg and M Bardies and M Lassmann and L Strigari and Mark Konijnenberg",

year = "2017",

doi = "10.1007/s00259-017-3707-3",

language = "Undefined/Unknown",

volume = "44",

pages = "1783--1786",

journal = "European Journal of Nuclear Medicine and Molecular Imaging",

issn = "1619-7070",

publisher = "Springer-Verlag",

number = "11",

}

Chiesa, C, Gleisner, KS, Flux, G, Gear, J, Walrand, S, Bacher, K, Eberlein, U, Visser, EP, Chouin, N, Ljungberg, M, Bardies, M, Lassmann, M, Strigari, L & Konijnenberg, M 2017, 'The conflict between treatment optimization and registration of radiopharmaceuticals with fixed activity posology in oncological nuclear medicine therapy', European Journal of Nuclear Medicine and Molecular Imaging, vol. 44, no. 11, pp. 1783-1786. https://doi.org/10.1007/s00259-017-3707-3

The conflict between treatment optimization and registration of radiopharmaceuticals with fixed activity posology in oncological nuclear medicine therapy. / Chiesa, C; Gleisner, KS; Flux, G et al.
In: European Journal of Nuclear Medicine and Molecular Imaging, Vol. 44, No. 11, 2017, p. 1783-1786.

Research output: Contribution to journal › Article › Academic › peer-review

TY - JOUR

T1 - The conflict between treatment optimization and registration of radiopharmaceuticals with fixed activity posology in oncological nuclear medicine therapy

AU - Chiesa, C

AU - Gleisner, KS

AU - Flux, G

AU - Gear, J

AU - Walrand, S

AU - Bacher, K

AU - Eberlein, U

AU - Visser, EP

AU - Chouin, N

AU - Ljungberg, M

AU - Bardies, M

AU - Lassmann, M

AU - Strigari, L

AU - Konijnenberg, Mark

PY - 2017

Y1 - 2017

U2 - 10.1007/s00259-017-3707-3

DO - 10.1007/s00259-017-3707-3

M3 - Article

C2 - 28536834

SN - 1619-7070

VL - 44

SP - 1783

EP - 1786

JO - European Journal of Nuclear Medicine and Molecular Imaging

JF - European Journal of Nuclear Medicine and Molecular Imaging

IS - 11

ER -